A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019

NCT ID: NCT04346602

Last Updated: 2020-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

132 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-01

Study Completion Date

2020-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study on the clinical and psychological characteristics of patients with coronavirus disease 2019 (COVID-2019)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective of this study is to study the clinical and psychological responses of patients with COVID-2019 during the whole treatment process. Including clinical symptoms, auxiliary examination results, and corresponding psychological changes, including depression, anxiety, insomnia, etc. This study will draw lessons about treatment and other better advices for other countries and regions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-2019

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with COVID-2019

Patients with COVID-2019 would be observed.

all treatment about COVID-2019

Intervention Type OTHER

All patients with COVID-2019 would receive treatment provided by the government and should comply with relevant laws and regulations.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

all treatment about COVID-2019

All patients with COVID-2019 would receive treatment provided by the government and should comply with relevant laws and regulations.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with COVID-2019

Exclusion Criteria

* No
Minimum Eligible Age

1 Year

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jilin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dong Yang

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dong Yang, Master

Role: PRINCIPAL_INVESTIGATOR

The First Hospital of Jilin University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

the First Hospital of Jilin University

Changchun, Jilin, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bai ling Yan, Doctor

Role: CONTACT

15804300278

Dong Yang, Master

Role: CONTACT

18844097668

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dong Yang, Master

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Yan B, Song L, Guo J, Wang Y, Peng L, Li D. Association Between Clinical Characteristics and Short-Term Outcomes in Adult Male COVID-19 Patients With Mild Clinical Symptoms: A Single-Center Observational Study. Front Med (Lausanne). 2021 Jan 5;7:571396. doi: 10.3389/fmed.2020.571396. eCollection 2020.

Reference Type DERIVED
PMID: 33469542 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

130004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.